Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020

GlobalData's Medical Devices sector report, "Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. Continuous Glucose Monitors are covered under this segment.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Blood Glucose Meters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Blood Glucose Meters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Blood Glucose Meters Overview

3 Products under Development

• 3.1 Blood Glucose Meters - Pipeline Products by Stage of Development
• 3.2 Blood Glucose Meters - Pipeline Products by Segment
• 3.3 Blood Glucose Meters - Pipeline Products by Territory
• 3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path
• 3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date
• 3.6 Blood Glucose Meters - Ongoing Clinical Trials

4 Blood Glucose Meters - Pipeline Products under Development by Companies

• 4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development
• 4.2 Blood Glucose Meters - Pipeline Products by Stage of Development

5 Blood Glucose Meters Companies and Product Overview

• 5.1 4a Medicom GmbH Company Overview
  • 5.1.1 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Abbott Diabetes Care Inc Company Overview
  • 5.2.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Advanced Biosensors-Ohio LLC Company Overview
  • 5.3.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Advanced Medical Electronics Corp Company Overview
  • 5.4.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Alertgy Inc Company Overview
  • 5.5.1 Alertgy Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Arkal Medical Inc (Inactive) Company Overview
  • 5.6.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Arkray Inc Company Overview
  • 5.7.1 Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Azurite Technologies, Inc. (Inactive) Company Overview
  • 5.8.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Bar-Ilan University Company Overview
  • 5.9.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Baylor University Company Overview
  • 5.10.1 Baylor University Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Biofi Medical Healthcare Pvt Ltd Company Overview
  • 5.11.1 Biofi Medical Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Biopeak Corp Company Overview
  • 5.12.1 Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Biorasis Inc Company Overview
  • 5.13.1 Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 BioTex Inc Company Overview
  • 5.14.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Biovotion AG Company Overview
  • 5.15.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Brain Beat Ltd Company Overview
  • 5.16.1 Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Brigham and Women's Hospital Company Overview
  • 5.17.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 CALISTO MEDICAL, INC. (Inactive) Company Overview
  • 5.18.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Callitas Therapeutics Inc Company Overview
  • 5.19.1 Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Cardiff University Company Overview
  • 5.20.1 Cardiff University Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 CGM3 Ltd Company Overview
  • 5.21.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Cirtec Medical LLC Company Overview
  • 5.22.1 Cirtec Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 City, University of London Company Overview
  • 5.23.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Columbia University Company Overview
  • 5.24.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 ConvaTec Group Plc Company Overview
  • 5.25.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Co-Optical Inc Company Overview
  • 5.26.1 Co-Optical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Cyber Medical Ltd Company Overview
  • 5.27.1 Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 DexCom Inc Company Overview
  • 5.28.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 DiaMonTech GmbH Company Overview
  • 5.29.1 DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 DirectSens GmbH Company Overview
  • 5.30.1 DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Echo Therapeutics Inc Company Overview
  • 5.31.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 Ecole Polytechnique Federale de Lausanne Company Overview
  • 5.32.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 eLutions Integrated Systems, Inc. Company Overview
  • 5.33.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 Emperra GmbH E-Health Technologies Company Overview
  • 5.34.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 EyeSense GmbH Company Overview
  • 5.35.1 EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 Firefly Health Pty Ltd Company Overview
  • 5.36.1 Firefly Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 Flowsion A/S Company Overview
  • 5.37.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
• 5.38 Gili Medical Ltd Company Overview
  • 5.38.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.39 Globe Medical Tech Inc (Inactive) Company Overview
  • 5.39.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.40 GlucoLight Corporation (Inactive) Company Overview
  • 5.40.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.41 GlucoMe Ltd Company Overview
  • 5.41.1 GlucoMe Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.42 Glucometrix AG Company Overview
  • 5.42.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.43 Glucosat Company Overview
  • 5.43.1 Glucosat Pipeline Products & Ongoing Clinical Trials Overview
• 5.44 Glucosense Diagnostics Ltd (Inactive) Company Overview
  • 5.44.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.45 GlucoSet AS Company Overview
  • 5.45.1 GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview
• 5.46 GlucoStats System Pte Ltd. Company Overview
  • 5.46.1 GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.47 Glucovation Inc Company Overview
  • 5.47.1 Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.48 GluMetrics Inc Company Overview
  • 5.48.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.49 Glusense Ltd Company Overview
  • 5.49.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.50 GlySens Inc Company Overview
  • 5.50.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.51 G-Sense Ltd. Company Overview
  • 5.51.1 G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.52 iGlyko, Inc. (Inactive) Company Overview
  • 5.52.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.53 Indigo Diabetes NV Company Overview
  • 5.53.1 Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview
• 5.54 InLight Solutions Inc. Company Overview
  • 5.54.1 InLight Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.55 Innopharmax Inc Company Overview
  • 5.55.1 Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.56 Innovosens AB Company Overview
  • 5.56.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.57 Insulet Corp Company Overview
  • 5.57.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.58 Integrated Medical Sensors Company Overview
  • 5.58.1 Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview
• 5.59 Integrity Applications Ltd Company Overview
  • 5.59.1 Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.60 IntelliDx Inc (Inactive) Company Overview
  • 5.60.1 IntelliDx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.61 Invivomon Inc (Inactive) Company Overview
  • 5.61.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.62 Invivosense ASA (Inactive) Company Overview
  • 5.62.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.63 I-Sens Inc Company Overview
  • 5.63.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.64 iSense Corporation (Inactive) Company Overview
  • 5.64.1 iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.65 KeenCAT Technologies Company Overview
  • 5.65.1 KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview
• 5.66 Keratin Biosciences Inc Company Overview
  • 5.66.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.67 Know Labs Inc Company Overview
  • 5.67.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.68 KTH Royal Institute of Technology Company Overview
  • 5.68.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.69 Lein Applied Diagnostics Limited Company Overview
  • 5.69.1 Lein Applied Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
• 5.70 LEMM Technologies, LLC Company Overview
  • 5.70.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.71 LifeScan Inc Company Overview
  • 5.71.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.72 LighTouch Medical, Inc. Company Overview
  • 5.72.1 LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.73 Luminous Medical Inc (Inactive) Company Overview
  • 5.73.1 Luminous Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.74 Lyte Labs Company Overview
  • 5.74.1 Lyte Labs Pipeline Products & Ongoing Clinical Trials Overview
• 5.75 Massachusetts Institute of Technology Company Overview
  • 5.75.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.76 Medical Wireless Sensing Ltd Company Overview
  • 5.76.1 Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.77 Medtronic Diabetes Company Overview
  • 5.77.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
• 5.78 Medtronic Plc Company Overview
  • 5.78.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.79 Mellitor Ltd Company Overview
  • 5.79.1 Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.80 Metronom Health Inc Company Overview
  • 5.80.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.81 mobiLIFE Company Overview
  • 5.81.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview
• 5.82 Mologic Ltd Company Overview
  • 5.82.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.83 Movano Inc Company Overview
  • 5.83.1 Movano Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.84 Nagasaki University Company Overview
  • 5.84.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview
• 5.85 Nemaura Medical Inc Company Overview
  • 5.85.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.86 Newton Photonics Inc Company Overview
  • 5.86.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.87 NIR Diagnostics Inc. (Inactive) Company Overview
  • 5.87.1 NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.88 Northwestern University Company Overview
  • 5.88.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
• 5.89 Orsus Medical Ltd Company Overview
  • 5.89.1 Orsus Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.90 Ossen Innovation Co Ltd Company Overview
  • 5.90.1 Ossen Innovation Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.91 Pelikan Technologies, Inc. (Inactive) Company Overview
  • 5.91.1 Pelikan Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.92 Pepex Biomedical, Inc. Company Overview
  • 5.92.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.93 PharmaTech Solutions Inc Company Overview
  • 5.93.1 PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.94 Pignolo SpA Company Overview
  • 5.94.1 Pignolo SpA Pipeline Products & Ongoing Clinical Trials Overview
• 5.95 PKvitality SAS Company Overview
  • 5.95.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview
• 5.96 POPS! Diabetes Care Inc Company Overview
  • 5.96.1 POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.97 PositiveID Corp Company Overview
  • 5.97.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.98 Prediktor Medical AS Company Overview
  • 5.98.1 Prediktor Medical AS Pipeline Products & Ongoing Clinical Trials Overview
• 5.99 Profusa Inc Company Overview
  • 5.99.1 Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.100 Purdue University Company Overview
  • 5.100.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
• 5.101 Q Step Technologies, Inc. Company Overview
  • 5.101.1 Q Step Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.102 Roche Diabetes Care Inc Company Overview
  • 5.102.1 Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.103 Senseonics Holdings Inc Company Overview
  • 5.103.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.104 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
  • 5.104.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.105 Sensyne Health Plc Company Overview
  • 5.105.1 Sensyne Health Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.106 Sensys Medical, Inc. Company Overview
  • 5.106.1 Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.107 Sentec Pte Ltd Company Overview
  • 5.107.1 Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.108 Senzime AB Company Overview
  • 5.108.1 Senzime AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.109 Shield Diagnostics Company Overview
  • 5.109.1 Shield Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
• 5.110 Singapore Biomicro Pte Ltd Company Overview
  • 5.110.1 Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.111 Socrates Health Solutions, Inc. Company Overview
  • 5.111.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.112 Solys Diagnostics Inc Company Overview
  • 5.112.1 Solys Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.113 Spire Biophotonics Lifesciences Company Overview
  • 5.113.1 Spire Biophotonics Lifesciences Pipeline Products & Ongoing Clinical Trials Overview
• 5.114 St. Louis Medical Devices Inc (Inactive) Company Overview
  • 5.114.1 St. Louis Medical Devices Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.115 Stony Brook University Company Overview
  • 5.115.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
• 5.116 Swansea University Company Overview
  • 5.116.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview
• 5.117 TecMed Inc Company Overview
  • 5.117.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.118 Tenax Therapeutics Inc Company Overview
  • 5.118.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.119 Terumo Corp Company Overview
  • 5.119.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.120 Texas A&M University Company Overview
  • 5.120.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
• 5.121 Ultradian Diagnostics LLC Company Overview
  • 5.121.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.122 University of California Berkeley Company Overview
  • 5.122.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
• 5.123 University of California Irvine Company Overview
  • 5.123.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
• 5.124 University of California San Diego Company Overview
  • 5.124.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
• 5.125 University of Central Florida Company Overview
  • 5.125.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
• 5.126 University of South Carolina Company Overview
  • 5.126.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
• 5.127 University of South Florida Company Overview
  • 5.127.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
• 5.128 University of Technology Sydney Company Overview
  • 5.128.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview
• 5.129 University of Texas at Arlington Company Overview
  • 5.129.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview
• 5.130 VeriTeQ Corporation Company Overview
  • 5.130.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview
• 5.131 Virginia Commonwealth University Company Overview
  • 5.131.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
• 5.132 Vytrace, Inc. Company Overview
  • 5.132.1 Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.133 WaveForm Technologies Inc Company Overview
  • 5.133.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.134 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview
  • 5.134.1 Xcellence in Bio Innovations & Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.135 Ypsomed Holding AG Company Overview
  • 5.135.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.136 Zansors LLC Company Overview
  • 5.136.1 Zansors LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.137 Zyvex Corp Company Overview
  • 5.137.1 Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Blood Glucose Meters- Recent Developments

• 6.1 Nov 10, 2020: Delta Electronics to increase stake in Lanner
• 6.2 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
• 6.3 Oct 11, 2020: Delta Electronics' Consolidated Sales Revenues for September 2020 Totaled NT$26,804 Million
• 6.4 Sep 08, 2020: Delta Electronics' consolidated sales revenues for August 2020 totaled NT$25,093 Million
• 6.5 Aug 31, 2020: Onduo's new prospective study published in the Journal of Medical Internet Research highlights the benefit of continuous glucose monitoring systems
• 6.6 Aug 10, 2020: Delta Electronics' consolidated sales revenues for july 2020 totaled NT$25,782 million
• 6.7 Aug 10, 2020: Helmsley awards $5 million to evaluate virtual diabetes specialty clinic model
• 6.8 Jul 28, 2020: Nemaura signs letter of intent to acquire Healthimation
• 6.9 Jul 27, 2020: Roche contract expansion to profile autoantibodies
• 6.10 Jun 15, 2020: Bayer U.S announces retirement of Philip Blake
• 6.11 Jun 09, 2020: Medtronic announces scientific data presentations at the American Diabetes Association 80th Scientific Sessions
• 6.12 May 04, 2020: Delta Electronics announces 2020-Q1 financial results
• 6.13 Apr 27, 2020: Sanmina reports second quarter financial results
• 6.14 Apr 16, 2020: Abbott reports first-quarter 2020 results
• 6.15 Apr 09, 2020: Delta Electronics' Consolidated Sales Revenues for March 2020 Totaled NT$21,083 Million
• 6.16 Mar 11, 2020: Welldoc announces collaboration with Dexcom to enhance the value of BlueStar with the Dexcom G6 CGM System
• 6.17 Mar 10, 2020: Nemaura Medical enters Into multiple verbal non-binding agreements for its sugarBEAT Platform
• 6.18 Mar 04, 2020: Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors
• 6.19 Mar 03, 2020: Nemaura Medical launches sugarBEAT App on play store ahead of its planned commercial launch of BEAT diabetes subscription service
• 6.20 Feb 28, 2020: Sensyne Health recognised for its impact in helping treat diabetes in pregnancy
• 6.21 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019
• 6.22 Feb 27, 2020: Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures
• 6.23 Feb 27, 2020: ConvaTec Group: Non-executive director appointment
• 6.24 Feb 26, 2020: Senseonics announces the FDA approval to continue the PROMISE sensor clinical study in an extended cohort to 365 days to gather feasibility data
• 6.25 Feb 25, 2020: Nemaura Medical plans head-to-head study with major glucose monitoring system
• 6.26 Feb 25, 2020: Sanofi announces resignation of Director
• 6.27 Feb 25, 2020: Henry Schein Named One of the 2020 World's Most Ethical Companies by Ethisphere
• 6.28 Feb 24, 2020: Senseonics reports at ATTD glycemic outcomes across adult age ranges with real-world Eversense CGM use
• 6.29 Feb 24, 2020: Advanced Hybrid Closed Loop System early feasibility data on patients undergoing unannounced meal challenges shows promising results
• 6.30 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
• 6.31 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
• 6.32 Feb 22, 2020: Bayer Cares Foundation donates over EUR 363,000 to support 94 social projects in 32 countries worldwide
• 6.33 Feb 21, 2020: Study from Ascensia demonstrates impact of BGMS selection on glycemic control when using a diabetes management app
• 6.34 Feb 21, 2020: Tenax announces the addition of Mayo Clinic expert, Dr. Barry Borlaug, to Scientific Advisory Board
• 6.35 Feb 20, 2020: New real-world data show that Abbott's FreeStyle Libre System delivers positive health outcomes for people with type 1 and type 2 diabetes
• 6.36 Feb 20, 2020: DECN announces market readiness of its GenUltimate TBG, adds to product's compatibility at the request of strategic partner, completes its universal translator GenExpidient! Device
• 6.37 Feb 20, 2020: Dexcom G6 Continuous Glucose Monitoring (CGM) System receives CE mark for use during pregnancy in the EU
• 6.38 Feb 20, 2020: Henry Schein reports record fourth quarter 2019 financial results from continuing operations
• 6.39 Feb 19, 2020: Abbott and Insulet partner on automated diabetes care
• 6.40 Feb 18, 2020: Senseonics announces a positive coverage decision for Eversense CGM from Cigna
• 6.41 Feb 18, 2020: Medtronic reports third quarter financial results 2020
• 6.42 Feb 13, 2020: Glooko names Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer
• 6.43 Feb 11, 2020: Senseonics announces partnership with Companion Medical
• 6.44 Feb 11, 2020: Nemaura Medical reports results and provides business update for the third quarter ended December 31, 2019
• 6.45 Feb 11, 2020: Henry Schein's Steven W. Kess named President of the Santa Fe Group
• 6.46 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
• 6.47 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan
• 6.48 Feb 06, 2020: Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
• 6.49 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors
• 6.50 Feb 03, 2020: 3D Systems expands Sanmina relationship to provide plastic printer manufacturing -- driving greater quality, availability, and reliability while improving 3d systems' cost structure
• 6.51 Jan 30, 2020: Roche reports very strong results in 2019
• 6.52 Jan 30, 2020: HR for Health and Henry Schein announce exclusive business relationship to provide doctors with new solutions to simplify human resources & payroll
• 6.53 Jan 29, 2020: UPS and Henry Schein sign agreement to explore Drone Delivery
• 6.54 Jan 27, 2020: Theraclion demonstrates its leadership in thyroid and veins none invasive treatments
• 6.55 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
• 6.56 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience
• 6.57 Jan 13, 2020: Livongo and Dexcom partner to integrate Dexcom's G6 Continuous Glucose Monitoring System into Livongo's Applied Health Signals Platform
• 6.58 Jan 09, 2020: Tandem Diabetes Care appoints new executive vice president of strategy and corporate development
• 6.59 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
• 6.60 Jan 07, 2020: Children's Choice Pediatrics Notifies Patients of Data Security Incident
• 6.61 Jan 02, 2020: Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020
• 6.62 Dec 23, 2019: Dexcom Partners with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain
• 6.63 Dec 20, 2019: Nemaura provides 2019 year-end corporate update
• 6.64 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group
• 6.65 Dec 18, 2019: Senzime recruits general manager to lead US operations
• 6.66 Dec 17, 2019: Nemaura Medical and Changing Health announce partnership to provide award-winning diabetes behavioral change services
• 6.67 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition
• 6.68 Dec 11, 2019: Glooko earns privacy shield certification for policies to safeguard diabetes patient data
• 6.69 Dec 10, 2019: Bayer to significantly step-up its sustainability efforts
• 6.70 Dec 09, 2019: Changes in the Board of Directors and the Corporate Executive Committee of Roche
• 6.71 Dec 05, 2019: Nemaura Medical announces expansion of SugarBEAT offering with BEAT Diabetes digital subscription services
• 6.72 Dec 04, 2019: OptiScan Biomedical announces peer-reviewed publications highlighting first-of-its-kind continuous monitoring platform for intensive care units
• 6.73 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
• 6.74 Dec 02, 2019: Senseonics launches Eversense CGM System with non-adjunctive claim in the U.S.

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Table 1: Blood Glucose Meters - Pipeline Products by Stage of Development
• Table 2: Blood Glucose Meters - Pipeline Products by Segment
• Table 3: Blood Glucose Meters - Pipeline Products by Territory
• Table 4: Blood Glucose Meters - Pipeline Products by Regulatory Path
• Table 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date
• Table 6: Blood Glucose Meters - Ongoing Clinical Trials
• Table 7: Blood Glucose Meters Companies - Pipeline Products by Stage of Development
• Table 8: Blood Glucose Meters - Pipeline Products by Stage of Development
• Table 9: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
• Table 10: GlucoPEARL - Product Status
• Table 11: GlucoPEARL - Product Description
• Table 12: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 13: Freestyle Libre 3 - Product Status
• Table 14: Freestyle Libre 3 - Product Description
• Table 15: Freestyle Libre Connected Insulin Pen - Product Status
• Table 16: Freestyle Libre Connected Insulin Pen - Product Description
• Table 17: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
• Table 18: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
• Table 19: Updated Hospital Blood Glucose Monitoring System - Product Status
• Table 20: Updated Hospital Blood Glucose Monitoring System - Product Description
• Table 21: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
• Table 22: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
• Table 23: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
• Table 24: Freestyle Libre 3 - FreeStyle Libre 3 Continuous Glucose Monitoring System Accuracy Study
• Table 25: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
• Table 26: My Medibit - Product Status
• Table 27: My Medibit - Product Description
• Table 28: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
• Table 29: Continuous Glucose Monitor - Product Status
• Table 30: Continuous Glucose Monitor - Product Description
• Table 31: Alertgy Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 32: Alertgy GM - Product Status
• Table 33: Alertgy GM - Product Description
• Table 34: Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• Table 35: GlucoPod CGM System - Product Status
• Table 36: GlucoPod CGM System - Product Description
• Table 37: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 38: GLUCOCARD S - Product Status
• Table 39: GLUCOCARD S - Product Description
• Table 40: GLUCOCARD S onyx - Product Status
• Table 41: GLUCOCARD S onyx - Product Description
• Table 42: GLUCOCARD W - Product Status
• Table 43: GLUCOCARD W - Product Description
• Table 44: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• Table 45: Blood Glucose Sensor - Product Status
• Table 46: Blood Glucose Sensor - Product Description
• Table 47: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
• Table 48: Biometric Watch - Product Status
• Table 49: Biometric Watch - Product Description
• Table 50: Baylor University Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

List of Figures

• Figure 1: Blood Glucose Meters - Pipeline Products by Stage of Development
• Figure 2: Blood Glucose Meters - Pipeline Products by Segment
• Figure 3: Blood Glucose Meters - Pipeline Products by Territory
• Figure 4: Blood Glucose Meters - Pipeline Products by Regulatory Path
• Figure 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date
• Figure 6: Blood Glucose Meters - Ongoing Clinical Trials